Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Adam Holland Insider Profile
4 Followers
Adam Holland, VP & CFO at Kirkland's, holds 0.00 shares in Tivity Health (Ticker: TVTY), holds 46.12K shares in Kirkland's (Ticker: KIRK).
Adam Holland has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Roles
VP & CFO
Roles that Adam Holland holds in companies
Most Profitable Insider Trade
Stock:
Tivity Health
(TVTY)
(TVTY)
Rating:Informative Buy
Date:Feb 28, 2020 - Feb 28, 2021
Return:+87.80%
The most profitable trade made by Adam Holland
Adam Holland's Trading History
Kirkland's
Jun 19, 2017
VP & CFO
Uninformative Sell
7.84K
$87.85K
Tivity Health
Jun 29, 2022
―
Uninformative Sell
3.11M
$0.00
List of latest transactions for each holding click on a transaction to see Adam Holland's performance on stock
You May Also Like
Adam Holland insider profile FAQ
What is the percentage of profitable transactions made by Adam Holland?
The percentage of profitable transactions made by Adam Holland is ―.
What is the average return per transaction made by Adam Holland?
The average return per transaction made by Adam Holland is ―.
What stocks does Adam Holland hold?
Adam Holland holds: KIRK, TVTY stocks.
What was Adam Holland’s latest transaction?
Adam Holland latest transaction was an Uninformative Sell of $3.11M.
What was Adam Holland's most profitable transaction?
Adam Holland’s most profitable transaction was an Informative Buy of TVTY stock on February 28, 2020. The return on the trade was 87.80%.
What is Adam Holland's role in Kirkland's?
Adam Holland's role in Kirkland's is VP & CFO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.